Skye Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Skye Bioscience, Inc. (SKYE) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $30.31 million as of 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2021-03-02
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $30.31M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $24.48M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $18.24M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $13.21M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2020-12-31 | $30.31M 10-K · filed 2021-03-02 |
| 2019-12-31 | $24.48M 10-K · filed 2020-03-23 |
| 2018-12-31 | $18.24M 10-K · filed 2019-03-14 |
| 2017-12-31 | $13.21M 10-K · filed 2018-03-19 |
| 2016-12-31 | $9.96M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |